|Articles|July 13, 2011

Section Editor - Dr Kamat

Photoclinic section editor CFP

Dr Kamat Professor of Pediatrics at Wayne State University in Detroit. He is also Director of the Institute of Medical Education and Vice Chair of Education at Children's Hospital of Michigan, both in Detroit.

Photoclinic Submission Guidelines.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Subscribe Now!

Related Content

Health system–based clinical pathway improves pediatric lipid screening rates

ByMorgan Ebert, Managing Editor

November 5th 2025

FDA approves linaclotide (Linzess) for pediatric patients aged 7 years and older with IBS-C

ByMorgan Ebert, Managing Editor

November 5th 2025

Silvana Bonilla, MD, discusses geographic patterns of H. Pylori in pediatric digestive disease

BySilvana Bonilla, MD

November 5th 2025

Environmental distress in children: Recognizing and responding to eco-anxiety

BySusan Solecki, DRPH, FNP-BC, PPCNP-BC

November 4th 2025

Ruth Lynfield, MD, on rebuilding vaccine confidence

Ruth Lynfield, MD, on rebuilding MMR vaccine confidence

ByRuth Lynfield, MD,John Parkinson

November 4th 2025

Latest CME

Video

Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice

Paul G. Auwaerter, MD, MBA; Paul P. Doghramji, MD, FAAFP; Aruna Subramanian, MD

Video

Clinical Consultations™: Addressing Elevated Phosphate Levels in Patients with END-STAGE Kidney Disease (ESKD)

Anil K. Agarwal, MD, FACP, FASN, FNKF, FASDIN; Jay B. Wish, MD

Multimedia

Advances In: Managing Hyperphosphatemia in Chronic Kidney Disease – Bridging Treatment Gaps With Novel Therapies

Glenn M. Chertow, MD, MPH; Anjay Rastogi, MD, PhD

Case-based Simulation

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Nicholas Doher, DO; Babak Tousi, MD

Multimedia

Burst CME™: Addressing Inadequate Response to Anti-TNF Therapy in Patients With Rheumatoid Arthritis

Jeffrey A. Sparks, MD, MMSc

Multimedia

Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis

Frank B. Cortazar, MD; Lindsay S. Lally, MD

Video

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Tina Bhutani, MD

Video

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP; Anders Carlson, MD; Jennifer B. Green, MD

Video

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Section Editor - Dr Kamat

Newsletter

Related Content

Health system–based clinical pathway improves pediatric lipid screening rates

FDA approves linaclotide (Linzess) for pediatric patients aged 7 years and older with IBS-C

Silvana Bonilla, MD, discusses geographic patterns of H. Pylori in pediatric digestive disease

Environmental distress in children: Recognizing and responding to eco-anxiety

Ruth Lynfield, MD, on rebuilding MMR vaccine confidence

Latest CME

Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice

Clinical Consultations™: Addressing Elevated Phosphate Levels in Patients with END-STAGE Kidney Disease (ESKD)

Advances In: Managing Hyperphosphatemia in Chronic Kidney Disease – Bridging Treatment Gaps With Novel Therapies

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Burst CME™: Addressing Inadequate Response to Anti-TNF Therapy in Patients With Rheumatoid Arthritis

Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Trending on Contemporary Pediatrics

FDA approves linaclotide (Linzess) for pediatric patients aged 7 years and older with IBS-C

Environmental distress in children: Recognizing and responding to eco-anxiety

Health system–based clinical pathway improves pediatric lipid screening rates

Silvana Bonilla, MD, discusses geographic patterns of H. Pylori in pediatric digestive disease

AHA issues 2025 CPR and ECC updates for choking, opioid overdose, and pediatric care